As of the latest SEC filings, Revolution Medicines, Inc. (RVMD) is held by 426 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $581,819,422.75 in market value, representing 0.03% of its portfolio.
Funds holding Revolution Medicines, Inc. (RVMD)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RVMD
- CIK:
- 0001628171
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $581,819,422.75 | 5,982,719 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.26% | $422,166,042.75 | 4,341,039 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.72% | $264,950,784.48 | 1,838,404 | Apr 30, 2026 | Jun 26, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.31% | $256,176,504.84 | 2,511,042 | Feb 28, 2026 | Apr 24, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.61% | $236,177,654.50 | 2,428,562 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.24% | $197,292,047.50 | 2,028,710 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.36% | $147,792,964.50 | 1,519,722 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 1.54% | $124,860,442.00 | 1,283,912 | Mar 31, 2026 | May 28, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 2.04% | $105,809,750.50 | 1,088,018 | Mar 31, 2026 | May 29, 2026 |
|
JAENX
Janus Henderson Enterprise Fund
|
MF | Independent / Boutique | 0.48% | $97,221,116.75 | 999,703 | Mar 31, 2026 | May 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.24% | $96,965,929.20 | 950,460 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.19% | $95,765,289.96 | 664,483 | Apr 30, 2026 | Jun 26, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.43% | $89,981,027.88 | 881,994 | Feb 28, 2026 | Apr 24, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.11% | $82,737,188.00 | 850,768 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.35% | $77,074,511.28 | 534,794 | Apr 30, 2026 | Jun 26, 2026 |
|
LGLQX
Lord Abbett Growth Leaders Fund
|
MF | Independent / Boutique | 1.00% | $75,900,798.00 | 526,650 | Apr 30, 2026 | Jun 29, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.31% | $71,121,406.64 | 697,132 | Feb 28, 2026 | Apr 24, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.13% | $63,091,910.00 | 648,760 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.29% | $62,375,232.04 | 611,402 | Feb 28, 2026 | Apr 24, 2026 |
|
JATTX
Janus Henderson Triton Fund
|
MF | Independent / Boutique | 1.04% | $53,942,824.50 | 554,682 | Mar 31, 2026 | May 29, 2026 |
|
SCHM
Schwab U.S. Mid-Cap ETF
|
ETF | Charles Schwab | 0.37% | $50,143,034.04 | 491,502 | Feb 28, 2026 | Apr 24, 2026 |
|
JAMRX
Janus Henderson Research Fund
|
MF | Independent / Boutique | 0.20% | $48,846,049.25 | 502,273 | Mar 31, 2026 | May 29, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.84% | $44,763,519.44 | 438,772 | Feb 28, 2026 | Apr 24, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 2.27% | $43,163,940.00 | 299,500 | Apr 30, 2026 | Jun 26, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.21% | $42,936,545.28 | 420,864 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)